Crowdonomics
WatchlistPortfolio
RAM Pharmaceuticals Inc.

Reg CF · Series B Common Stock · Sep 2025

ClosedReached targetReg CFCommon Equity
via DealMaker · last checked Sep 28, 2026
Raised
$28.7K / $1.2M max
2% of ceiling
Investors
—
—
Post-money valuation
$18.2M
pre-money + amount raised

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
FY2023
$0
FY2024
RevenueNet income
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
1
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Jan 5, 2026
    • Deadline Jan 16, 2026 → Apr 30, 2026

    “This material amendment is filed to change the closing date from January 16th to April 30, 2026, and the change of employees to 1.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$18.1M
Post-money$18.2M

Offering details

Target$10,200
Max$1,235,000
Min investment—
OpenedSep 23, 2025
DeadlineApr 1, 2026
ClosedApr 1, 2026
Days active190

Links & provenance

SEC filing
Source: SEC EDGAR
0001872856-25-000006
Last synced Sep 28, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.